These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8524124)

  • 1. Assays for inhibitors of CAAX farnesyltransferase in vitro and in intact cells.
    James GL; Brown MS; Goldstein JL
    Methods Enzymol; 1995; 255():38-46. PubMed ID: 8524124
    [No Abstract]   [Full Text] [Related]  

  • 2. Potent, cell active, non-thiol tetrapeptide inhibitors of farnesyltransferase.
    Hunt JT; Lee VG; Leftheris K; Seizinger B; Carboni J; Mabus J; Ricca C; Yan N; Manne V
    J Med Chem; 1996 Jan; 39(2):353-8. PubMed ID: 8558502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-peptide mimetic of Ras-CAAX: selective inhibition of farnesyltransferase and Ras processing.
    Vogt A; Qian Y; Blaskovich MA; Fossum RD; Hamilton AD; Sebti SM
    J Biol Chem; 1995 Jan; 270(2):660-4. PubMed ID: 7822292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of farnesyltransferase and Ras processing peptidase.
    Hall CC; Watkins JD; Ferguson SB; Foley LH; Georgopapadakou NH
    Biochem Biophys Res Commun; 1995 Dec; 217(3):728-32. PubMed ID: 8554591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesyltransferase inhibitors: a new class of cancer chemotherapeutics.
    Koblan KS; Kohl NE; Omer CA; Anthony NJ; Conner MW; deSolms SJ; Williams TM; Graham SL; Hartman GD; Oliff A; Gibbs JB
    Biochem Soc Trans; 1996 Aug; 24(3):688-92. PubMed ID: 8878827
    [No Abstract]   [Full Text] [Related]  

  • 6. Tetrapeptide inhibitors of protein farnesyltransferase: amino-terminal substitution in phenylalanine-containing tetrapeptides restores farnesylation.
    Brown MS; Goldstein JL; Paris KJ; Burnier JP; Marsters JC
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8313-6. PubMed ID: 1518863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonfarnesylated tetrapeptide inhibitors of protein farnesyltransferase.
    Goldstein JL; Brown MS; Stradley SJ; Reiss Y; Gierasch LM
    J Biol Chem; 1991 Aug; 266(24):15575-8. PubMed ID: 1874715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of neutrophil priming by inhibitors of farnesyl transferase.
    Elmore MA; Daniels RH; Hill ME; Finnen MJ
    Biochem Soc Trans; 1997 May; 25(2):253S. PubMed ID: 9191297
    [No Abstract]   [Full Text] [Related]  

  • 9. The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics.
    Long SB; Hancock PJ; Kral AM; Hellinga HW; Beese LS
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):12948-53. PubMed ID: 11687658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of tripeptidyl farnesyltransferase inhibitors.
    Lee HY; Sohn JH; Kwon BM
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1599-602. PubMed ID: 12039571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of protein prenyltransferases from bovine brain and baculovirus expression system.
    Moomaw JF; Zhang FL; Casey PJ
    Methods Enzymol; 1995; 250():12-21. PubMed ID: 7651144
    [No Abstract]   [Full Text] [Related]  

  • 12. Pseudodipeptide inhibitors of protein farnesyltransferase.
    deSolms SJ; Deana AA; Giuliani EA; Graham SL; Kohl NE; Mosser SD; Oliff AI; Pompliano DL; Rands E; Scholz TH
    J Med Chem; 1995 Sep; 38(20):3967-71. PubMed ID: 7562930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fluorescence assay for geranylgeranyl transferase type I.
    Pickett WC; Zhang FL; Silverstrim C; Schow SR; Wick MM; Kerwar SS
    Anal Biochem; 1995 Feb; 225(1):60-3. PubMed ID: 7778787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of recombinant Rab geranylgeranyltransferase and Rab escort proteins.
    Armstrong SA; Brown MS; Goldstein JL; Seabra MC
    Methods Enzymol; 1995; 257():30-41. PubMed ID: 8583933
    [No Abstract]   [Full Text] [Related]  

  • 15. Pepticinnamins, new farnesyl-protein transferase inhibitors produced by an actinomycete. II. Structural elucidation of pepticinnamin E.
    Shiomi K; Yang H; Inokoshi J; Van der Pyl D; Nakagawa A; Takeshima H; Omura S
    J Antibiot (Tokyo); 1993 Feb; 46(2):229-34. PubMed ID: 8468236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21ras farnesyltransferase: purification and properties of the enzyme.
    Reiss Y; Seabra MC; Brown MS; Goldstein JL
    Biochem Soc Trans; 1992 May; 20(2):487-8. PubMed ID: 1397646
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in the development of farnesyltransferase inhibitors: substrate recognition by protein farnesyltransferase.
    Yang W; Del Villar K; Urano J; Mitsuzawa H; Tamanoi F
    J Cell Biochem Suppl; 1997; 27():12-9. PubMed ID: 9591188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence requirement for peptide recognition by rat brain p21ras protein farnesyltransferase.
    Reiss Y; Stradley SJ; Gierasch LM; Brown MS; Goldstein JL
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):732-6. PubMed ID: 1992464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of K-RasBV12 proteins to farnesyltransferase inhibitors in Rat1 cells.
    James G; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4454-8. PubMed ID: 8633088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the hydrophobic pocket of farnesyltransferase: aromatic substitution of CAAX peptidomimetics leads to highly potent inhibitors.
    Qian Y; Marugan JJ; Fossum RD; Vogt A; Sebti SM; Hamilton AD
    Bioorg Med Chem; 1999 Dec; 7(12):3011-24. PubMed ID: 10658608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.